nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2E1—Dacarbazine—muscle cancer	0.29	0.308	CbGbCtD
Methimazole—CYP1A2—Dacarbazine—muscle cancer	0.168	0.178	CbGbCtD
Methimazole—CYP2E1—Etoposide—muscle cancer	0.142	0.151	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—muscle cancer	0.0954	0.101	CbGbCtD
Methimazole—CYP1A2—Etoposide—muscle cancer	0.082	0.0871	CbGbCtD
Methimazole—CYP3A4—Vincristine—muscle cancer	0.0469	0.0498	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—muscle cancer	0.0461	0.0489	CbGbCtD
Methimazole—CYP3A4—Etoposide—muscle cancer	0.043	0.0456	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—muscle cancer	0.0293	0.0311	CbGbCtD
Methimazole—Pigmentation disorder—Etoposide—muscle cancer	0.0047	0.0806	CcSEcCtD
Methimazole—Neuritis—Vincristine—muscle cancer	0.00259	0.0445	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—muscle cancer	0.00244	0.0418	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—muscle cancer	0.00204	0.0349	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—muscle cancer	0.00113	0.0194	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—muscle cancer	0.00109	0.0187	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—muscle cancer	0.00109	0.0187	CcSEcCtD
Methimazole—Neuropathy peripheral—Vincristine—muscle cancer	0.00106	0.0182	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—muscle cancer	0.001	0.0172	CcSEcCtD
Methimazole—Alopecia—Dactinomycin—muscle cancer	0.000962	0.0165	CcSEcCtD
Methimazole—Aplastic anaemia—Methotrexate—muscle cancer	0.000882	0.0151	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—muscle cancer	0.00086	0.0148	CcSEcCtD
Methimazole—Alopecia—Vincristine—muscle cancer	0.000859	0.0147	CcSEcCtD
Methimazole—Jaundice—Etoposide—muscle cancer	0.000855	0.0147	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—muscle cancer	0.000848	0.0146	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—muscle cancer	0.000819	0.0141	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—muscle cancer	0.000807	0.0138	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—muscle cancer	0.0008	0.0137	CcSEcCtD
Methimazole—Oedema—Dactinomycin—muscle cancer	0.000773	0.0133	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—muscle cancer	0.000764	0.0131	CcSEcCtD
Methimazole—Vertigo—Vincristine—muscle cancer	0.000761	0.0131	CcSEcCtD
Methimazole—Leukopenia—Vincristine—muscle cancer	0.000758	0.013	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—muscle cancer	0.000757	0.013	CcSEcCtD
Methimazole—Myalgia—Vincristine—muscle cancer	0.000721	0.0124	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000705	0.0121	CcSEcCtD
Methimazole—Alopecia—Etoposide—muscle cancer	0.000696	0.0119	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—muscle cancer	0.000692	0.0119	CcSEcCtD
Methimazole—Oedema—Vincristine—muscle cancer	0.000691	0.0119	CcSEcCtD
Methimazole—Thrombocytopenia—Vincristine—muscle cancer	0.000677	0.0116	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00063	0.0108	CcSEcCtD
Methimazole—Paraesthesia—Vincristine—muscle cancer	0.00062	0.0106	CcSEcCtD
Methimazole—Vertigo—Etoposide—muscle cancer	0.000616	0.0106	CcSEcCtD
Methimazole—Leukopenia—Etoposide—muscle cancer	0.000614	0.0105	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—muscle cancer	0.000611	0.0105	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—muscle cancer	0.000548	0.0094	CcSEcCtD
Methimazole—Body temperature increased—Vincristine—muscle cancer	0.000546	0.00937	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—muscle cancer	0.000526	0.00902	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—muscle cancer	0.000503	0.00862	CcSEcCtD
Methimazole—Somnolence—Etoposide—muscle cancer	0.000498	0.00854	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—muscle cancer	0.000492	0.00844	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—muscle cancer	0.000491	0.00842	CcSEcCtD
Methimazole—Rash—Dactinomycin—muscle cancer	0.000488	0.00837	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—muscle cancer	0.000472	0.0081	CcSEcCtD
Methimazole—Nausea—Dactinomycin—muscle cancer	0.000459	0.00788	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—muscle cancer	0.000455	0.00781	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000446	0.00766	CcSEcCtD
Methimazole—Urticaria—Etoposide—muscle cancer	0.000445	0.00763	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—muscle cancer	0.000444	0.00761	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—muscle cancer	0.000442	0.00759	CcSEcCtD
Methimazole—Vomiting—Vincristine—muscle cancer	0.000439	0.00754	CcSEcCtD
Methimazole—Rash—Vincristine—muscle cancer	0.000436	0.00747	CcSEcCtD
Methimazole—Dermatitis—Vincristine—muscle cancer	0.000435	0.00747	CcSEcCtD
Methimazole—Headache—Vincristine—muscle cancer	0.000433	0.00743	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—muscle cancer	0.000425	0.00729	CcSEcCtD
Methimazole—Alopecia—Methotrexate—muscle cancer	0.000417	0.00715	CcSEcCtD
Methimazole—Nausea—Vincristine—muscle cancer	0.00041	0.00704	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—muscle cancer	0.000409	0.00701	CcSEcCtD
Methimazole—Pruritus—Etoposide—muscle cancer	0.000396	0.00679	CcSEcCtD
Methimazole—Vertigo—Methotrexate—muscle cancer	0.000369	0.00633	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—muscle cancer	0.000368	0.00631	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—muscle cancer	0.000361	0.0062	CcSEcCtD
Methimazole—Vomiting—Etoposide—muscle cancer	0.000356	0.00611	CcSEcCtD
Methimazole—Rash—Etoposide—muscle cancer	0.000353	0.00606	CcSEcCtD
Methimazole—Dermatitis—Etoposide—muscle cancer	0.000353	0.00605	CcSEcCtD
Methimazole—Headache—Etoposide—muscle cancer	0.000351	0.00602	CcSEcCtD
Methimazole—Myalgia—Methotrexate—muscle cancer	0.00035	0.006	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—muscle cancer	0.00035	0.006	CcSEcCtD
Methimazole—Nausea—Etoposide—muscle cancer	0.000332	0.0057	CcSEcCtD
Methimazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000328	0.00563	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—muscle cancer	0.00032	0.00548	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—muscle cancer	0.000318	0.00546	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000305	0.00524	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—muscle cancer	0.000303	0.0052	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—muscle cancer	0.000303	0.0052	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—muscle cancer	0.000301	0.00517	CcSEcCtD
Methimazole—Somnolence—Methotrexate—muscle cancer	0.000298	0.00511	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—muscle cancer	0.000295	0.00506	CcSEcCtD
Methimazole—Oedema—Doxorubicin—muscle cancer	0.00029	0.00498	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000284	0.00488	CcSEcCtD
Methimazole—Urticaria—Methotrexate—muscle cancer	0.000266	0.00457	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—muscle cancer	0.000265	0.00455	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000264	0.00454	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—muscle cancer	0.000261	0.00447	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—muscle cancer	0.000258	0.00443	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—muscle cancer	0.000256	0.00438	CcSEcCtD
Methimazole—Pruritus—Methotrexate—muscle cancer	0.000237	0.00407	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—muscle cancer	0.000231	0.00396	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—muscle cancer	0.000229	0.00394	CcSEcCtD
Methimazole—Vomiting—Methotrexate—muscle cancer	0.000213	0.00366	CcSEcCtD
Methimazole—Rash—Methotrexate—muscle cancer	0.000211	0.00363	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—muscle cancer	0.000211	0.00362	CcSEcCtD
Methimazole—Headache—Methotrexate—muscle cancer	0.00021	0.0036	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—muscle cancer	0.000205	0.00352	CcSEcCtD
Methimazole—Nausea—Methotrexate—muscle cancer	0.000199	0.00342	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—muscle cancer	0.000185	0.00317	CcSEcCtD
Methimazole—Rash—Doxorubicin—muscle cancer	0.000183	0.00314	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—muscle cancer	0.000183	0.00314	CcSEcCtD
Methimazole—Headache—Doxorubicin—muscle cancer	0.000182	0.00312	CcSEcCtD
Methimazole—Nausea—Doxorubicin—muscle cancer	0.000172	0.00296	CcSEcCtD
